Abstract

Muscle cells are potential targets of many arboviruses, such as Ross River, Dengue, Sindbis, and chikungunya viruses, that may be involved in the physiopathological course of the infection. During the recent outbreak of Zika virus (ZIKV), myalgia was one of the most frequently reported symptoms. We investigated the susceptibility of human muscle cells to ZIKV infection. Using an in vitro model of human primary myoblasts that can be differentiated into myotubes, we found that myoblasts can be productively infected by ZIKV. In contrast, myotubes were shown to be resistant to ZIKV infection, suggesting a differentiation-dependent susceptibility. Infection was accompanied by a caspase-independent cytopathic effect, associated with paraptosis-like cytoplasmic vacuolization. Proteomic profiling was performed 24h and 48h post-infection in cells infected with two different isolates. Proteome changes indicate that ZIKV infection induces an upregulation of proteins involved in the activation of the Interferon type I pathway, and a downregulation of protein synthesis. This work constitutes the first observation of primary human muscle cells susceptibility to ZIKV infection, and differentiation-dependent restriction of infection from myoblasts to myotubes. Since myoblasts constitute the reservoir of stem cells involved in reparation/regeneration in muscle tissue, the infection of muscle cells and the viral-induced alterations observed here could have consequences in ZIKV infection pathogenesis.

Highlights

  • Zika virus (ZIKV) is a mosquito-borne flavivirus transmitted by many Aedes species (Ae. africanus, Ae aegypti, Ae. hensilli, Ae. luteocephalus)

  • We investigated the susceptibility of human muscle cells to ZIKV infection

  • Using an in vitro model of human muscle stem cells that can be differentiated into differentiated muscle cells, we found that myoblasts can be infected by ZIKV

Read more

Summary

Introduction

Zika virus (ZIKV) is a mosquito-borne flavivirus transmitted by many Aedes species (Ae. africanus, Ae aegypti, Ae. hensilli, Ae. luteocephalus). Up to 2007, cases of Zika infection were sporadically reported in Africa and South East Asia, and were associated with mild clinical symptoms. The first reported epidemics occurred on the Yap archipelago (Federated States of Micronesia) in 2007 [2] and in French Polynesia in 2013 with 28,000 infections in the first 4 months of the epidemic [3]. In May 2015, the first cases appeared in the northeast regions of Brazil, preceding the largest Zika virus outbreak in this country. Around 30,000 clinical cases have been reported in 2016, but the total number of individuals infected remains unknown and could reach one million cases. ZIKV has spread throughout Central and South America and the Caribbean, as well as the United States [4]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call